Skip to content
MarketScale
‹ Back to IndustriesHealthcare

What Safety Measures Will Guests Expect as Travel Booms this Summer?

On this episode of A Move In The Light Direction, a podcast by Surfacide UV Technology, host Daniel Litwin talked with Wendy Walling, Director of Global Marketing at Intellego Technologies, and Jeff Veenhuis, President and CEO, Surfacide Manufacturing. The trio spoke about trends in summer travels as the U.S. meets new highs in travel demand…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
What Safety Measures Will Guests Expect as Travel Booms this Summer?

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

On this episode of A Move In The Light Direction, a podcast by Surfacide UV Technology, host Daniel Litwin talked with Wendy Walling, Director of Global Marketing at Intellego Technologies, and Jeff Veenhuis, President and CEO, Surfacide Manufacturing.

The trio spoke about trends in summer travels as the U.S. meets new highs in travel demand and how these will impact safety expectations for brick-and-mortar locations. Overall, travel demand has increased for the summer, which is good news for the travel industry.

As the European Union recommends the return of non-essential travel for U.S. passengers to boost their economy, the U.S. itself is seeing travel numbers similar to 2019, which was an excellent year for travel.

We recently crossed 2 million passengers crossing check-in thresholds in a single day, the TSA reported. Venues across the country are also seeing high traffic again, which also impacts the hospitality industry, but safety expectations have changed due to COVID.

“Whether it’s travel or hotels, consumers are really looking for safety protocols,” Walling said. “They want to see it in the policy and in the practice. They want to see evidence of it. The brands I think are going to do well and manage the influx of travel again are the ones prepared to handle that.”

However, not everything is so peachy in the travel industry, as the world-shaking effect of COVID-19 lingers on with new variants. These could potentially lead to more restrictions on travelers and even more expectations for health and well-being.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

OpenAI’s ChatGPT for Healthcare is getting wired into Epic

OpenAI’s ChatGPT for Healthcare is getting wired into Epic

ChatGPT for Healthcare can now read from Epic. UCSF Health is piloting the read-only integration, according to Fierce Healthcare and Becker’s Hospital Review. For CIOs, the work is permissions, auditability, and clinical validation in Epic workflows.

  • 01The “read-only” label doesn’t remove governance work, it moves it to permissions mapping, audit logs, and connector scope design inside Epic-supported workflows.
  • 02OpenAI’s published clinician review results (99.1% rated safe across 4,363 ratings) are a useful benchmark, but they still need local validation on your own note templates, meds workflows, and specialty mix.

Sep 7, 2026

The EU’s MDR delay buys time, but it won’t clear your commissioning bottleneck

The European Commission backed extending EU MDR transition deadlines to December 2027 and December 2028, Medical Design & Outsourcing reported. It buys time, not ramp-up capacity. Design News cites digital commissioning and machine digital twins to cut “power-on” surprises and speed validation and operator training.

  • 01If an EU portfolio includes Class III, December 2027 is now the planning anchor, but the internal gating item may shift to validation capacity and automation readiness, not paperwork.
  • 02Digital commissioning is becoming a procurement spec, not a buzzword, because it lets teams run DFM/DFA learning loops before hardware is built, which Design News notes is meant to reduce machine power-on surprises.

Sep 5, 2026

HCA’s Q1 was not about volume. It was about coverage and collecting cash

HCA Healthcare reaffirmed 2026 guidance after Q1 weather and a muted respiratory season cut adjusted EBITDA by about $180 million, according to HealthLeaders and Fierce Healthcare. Payer mix shifted fast. Exchange admissions fell about 15% and uninsured admissions rose about 16%, Fierce reported.

  • 01A mild flu season can be a margin event: HCA tied a 42% drop in respiratory admissions to a roughly $180M adjusted EBITDA hit (HealthLeaders, Fierce Healthcare).
  • 02The 2026 risk is sliding from demand to coverage: HCA cited a $600M–$900M full-year EBITDA headwind from exchange-related changes, with $150M already in Q1 (HealthLeaders, Fierce Healthcare).
  • 03Supplemental payments are becoming an operating capability, not a windfall: HCA said Q1 Medicaid program net benefit was about $200M vs $80M expected (HealthLeaders, Fierce Healthcare), putting state-by-state reimbursement strategy on the CFO’s critical path.

Sep 5, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512